Evidence map›Paper›PMID 29502537›Full record

ArticleGenetics research2018

Association of tribbles homologue 1 gene expression in human umbilical vein endothelial cells with duration of intrauterine exposure to hyperglycaemia.

Polina V Popova, Liudmila B Vasileva, Alexandra S Tkachuk, Maxim V Puzanov, Yana A Bolotko, Evgenii A Pustozerov, Andrey S Gerasimov, Irina E Zazerskaya, Olga A Li, Elena Y Vasilyeva and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Genetics research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Polina V PopovaAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Liudmila B VasilevaAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Alexandra S TkachukAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Maxim V PuzanovAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Yana A BolotkoAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Evgenii A PustozerovAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Andrey S GerasimovAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Irina E ZazerskayaAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Olga A LiAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Elena Y VasilyevaAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Anna A KostarevaAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Renata I DmitrievaAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Elena N GrinevaAlmazov National Medical Research Centre,Saint Petersburg,Russian Federation.
Federal Almazov North-West Medical Research Centre · RUFirst Pavlov State Medical University of St. Petersburg · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maternal gestational diabetes mellitus (GDM) is considered to be an important factor that epigenetically predisposes offspring to metabolic and cardiovascular diseases. However, the mechanisms of how intrauterine hyperglycaemia affects offspring have not been thoroughly studied. The mammalian tribbles homologue 1 (TRIB1) gene is associated with plasma lipid concentrations and coronary artery disease (CAD). Our aim was to study the effect of GDM and its treatment terms on the level of TRIB1 gene expression in human umbilical vein endothelial cells (HUVECs) of newborns from women with and without GDM. The study included 50 women with GDM and 25 women without GDM (control group). Women with GDM were divided into three groups according to their gestational age when the treatment of GDM started: 24-28 weeks (GDM1, N = 16), 29-32 weeks (GDM2, N = 25) and >34 weeks (GDM3, N = 9). The levels of TRIB1 gene expression in GDM3, GDM2, GDM1 and control groups were 2.8 ± 1.1, 4.2 ± 2.4, 6.0 ± 3.4 and 8.1 ± 6.1, respectively (p = 0.001). After comparison in pairs the difference was significant for the following pairs: GDM2-control (p = 0.004), GDM3-control (p = 0.002), GDM1-GDM3 (p = 0.012). Notably, if treatment had been started before the 28th week of gestation, the difference in TRIB1 gene expression in HUVECs was not significant (p = 0.320 for comparison between GDM1 and control groups). Our findings support the hypothesis that TRIB1 gene expression in HUVECs depends on the duration of intrauterine exposure to hyperglycaemia.

Indexed as

Genetic Association StudiesAdultDiabetes, GestationalFemaleGene ExpressionGestational AgeHumansHuman Umbilical Vein Endothelial CellsHyperglycemiaInfant, NewbornIntracellular Signaling Peptides and ProteinsPregnancyProtein Serine-Threonine KinasesTime FactorsIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesTRIB1 protein, human

Identifiers

PMID29502537
PMCPMC6865169
OpenAlexW2789390766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.